ACCUSTEM SCIENCES, INC.

ACUT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents
Accounts Receivable
Inventory
Total Current Assets $49.4K $50.4K $129.8K $932.0K $1.4M
Property, Plant & Equipment $418 $4.0K $7.7K
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $1.5M $50.9K $133.9K $939.7K $1.4M
Liabilities
Accounts Payable $703.8K $804.6K $578.4K $311.8K $388.7K
Total Current Liabilities $5.0M $3.4M $2.2M $1.1M $702.7K
Long-Term Debt
Total Liabilities $5.0M $3.4M $2.2M $1.1M $702.7K
Stockholders' Equity
Retained Earnings $-9.8M $-8.0M $-6.5M $-4.5M $-724.9K
Total Stockholders' Equity $-3.4M $-3.3M $-2.1M $-139.6K $650.7K $1.3M